JO3601B1 - مركبات 6 ، 7 ثاني هيدرو بيرازولو [ 1، 5 الفا ] بيرازين – 4 (5 يد) – اون واستخدامها كمنظمات الوسترية سلبية لمستقبلات ملجور 2 - Google Patents
مركبات 6 ، 7 ثاني هيدرو بيرازولو [ 1، 5 الفا ] بيرازين – 4 (5 يد) – اون واستخدامها كمنظمات الوسترية سلبية لمستقبلات ملجور 2Info
- Publication number
- JO3601B1 JO3601B1 JOP/2015/0178A JOP20150178A JO3601B1 JO 3601 B1 JO3601 B1 JO 3601B1 JO P20150178 A JOP20150178 A JO P20150178A JO 3601 B1 JO3601 B1 JO 3601B1
- Authority
- JO
- Jordan
- Prior art keywords
- compounds
- dihydropyrazolo
- pyrazin
- allosteric modulators
- negative allosteric
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
يتعلق الاختراع الحالي بمشتقات 6 ، 7 ثاني هيدرو بيرازولو [ 1، 5 الفا ] بيرازين – 4 (5 يد) – اون بصفتها منظمات الوسترية سلبية لمستقبل جلوتاميت ميتاتروبي نوع فرعي 2. كما يتعلق الاختراع بتركيبات صيدلانية تشتمل على هذه المركبات وبعمليات تحضير هذه المركبات والتركيبات واستخدام هذه المركبات والتركيبات لمنع أو معالجة الاضطرابات التي تتضمن مستقبل جلوتاميت ميتاتروبي نوع فرعي 2 .
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14179599 | 2014-08-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
JO3601B1 true JO3601B1 (ar) | 2020-07-05 |
Family
ID=51257438
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JOP/2015/0178A JO3601B1 (ar) | 2014-08-01 | 2015-07-27 | مركبات 6 ، 7 ثاني هيدرو بيرازولو [ 1، 5 الفا ] بيرازين – 4 (5 يد) – اون واستخدامها كمنظمات الوسترية سلبية لمستقبلات ملجور 2 |
Country Status (15)
Country | Link |
---|---|
US (1) | US10112949B2 (ar) |
EP (1) | EP3174880B1 (ar) |
JP (1) | JP6615864B2 (ar) |
KR (1) | KR102531693B1 (ar) |
CN (1) | CN106573935B (ar) |
AR (1) | AR101393A1 (ar) |
AU (1) | AU2015295299B2 (ar) |
BR (1) | BR112017001998A2 (ar) |
CA (1) | CA2954218C (ar) |
EA (1) | EA031038B1 (ar) |
ES (1) | ES2702192T3 (ar) |
JO (1) | JO3601B1 (ar) |
MX (1) | MX2017001453A (ar) |
TW (1) | TWI696625B (ar) |
WO (1) | WO2016016381A1 (ar) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JOP20150179B1 (ar) | 2014-08-01 | 2021-08-17 | Janssen Pharmaceutica Nv | مركبات 6 ، 7 ثاني هيدرو بيرازولو [ 1، 5 الفا ] بيرازين – 4 (5 يد) – اون واستخدامها كمنظمات الوسترية سلبية لمستقبلات ملجور 2 |
JOP20150177B1 (ar) | 2014-08-01 | 2021-08-17 | Janssen Pharmaceutica Nv | مركبات 6 ، 7 ثاني هيدرو بيرازولو [ 1، 5 الفا ] بيرازين – 4 (5 يد) – اون واستخدامها كمنظمات الوسترية سلبية لمستقبلات ملجور 2 |
CA2967542C (en) | 2014-12-03 | 2022-11-29 | Janssen Pharmaceutica Nv | Radiolabelled mglur2 pet ligands |
EP3227295B1 (en) | 2014-12-03 | 2019-02-20 | Janssen Pharmaceutica NV | 6,7-dihydropyrazolo[1,5- ]pyrazin-4(5h)-one compounds and their use as negative allosteric modulators of mglu2 receptors |
SI3389727T1 (sl) * | 2015-12-18 | 2020-10-30 | Janssen Pharmaceutica Nv | Radioaktivno označeni ligandi PET MGLUR2/3 |
ES2820823T3 (es) | 2015-12-18 | 2021-04-22 | Janssen Pharmaceutica Nv | Ligandos PET mGluR2/3 radiomarcados |
AU2018373464B2 (en) | 2017-11-24 | 2022-12-08 | Sumitomo Pharma Co., Ltd. | 6,7-dihydropyrazolo[1,5-a] pyrazinone derivative and medical use thereof |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102004054665A1 (de) * | 2004-11-12 | 2006-05-18 | Bayer Cropscience Gmbh | Substituierte bi- und tricyclische Pyrazol-Derivate Verfahren zur Herstellung und Verwendung als Herbizide und Pflanzenwachstumsregulatoren |
RU2412943C2 (ru) * | 2005-03-23 | 2011-02-27 | Ф. Хоффманн-Ля Рош Аг | ПРОИЗВОДНЫЕ АЦЕТИЛЕНИЛ-ПИРАЗОЛО-ПИРИМИДИНА В КАЧЕСТВЕ АНТАГОНИСТОВ mGluR2 |
CN102439008B (zh) | 2009-05-12 | 2015-04-29 | 杨森制药有限公司 | 1,2,4-***并[4,3-a]吡啶衍生物及其用于治疗或预防神经和精神病症的用途 |
AU2011343477A1 (en) * | 2010-12-17 | 2013-07-04 | Vanderbilt University | Bicyclic triazole and pyrazole lactams as allosteric modulators of mGluR5 receptors |
WO2012172093A1 (en) * | 2011-06-17 | 2012-12-20 | Merz Pharma Gmbh & Co. Kgaa | Dihydroindolizine derivate as metabotropic glutamate receptor modulators |
MY167423A (en) | 2011-11-03 | 2018-08-27 | Merck Sharp & Dohme | Quinoline carboxamide and quinoline carbonitrile derivatives as mglur2-negative allosteric modulators,compositions,and their use |
EP2666775A1 (en) | 2012-05-21 | 2013-11-27 | Domain Therapeutics | Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group II metabotropic glutamate receptors |
CN104736156A (zh) | 2012-06-20 | 2015-06-24 | 范德比尔特大学 | 作为mglur5受体变构调节剂的取代的双环烷氧基吡唑类似物 |
US20130345204A1 (en) | 2012-06-20 | 2013-12-26 | Vanderbilt University | Substituted bicyclic cycloalkyl pyrazole lactam analogs as allosteric modulators of mglur5 receptors |
US20130345205A1 (en) * | 2012-06-20 | 2013-12-26 | Vanderbilt University | Substituted bicyclic aralkyl pyrazole lactam analogs as allosteric modulators of mglur5 receptors |
EP2925292A1 (en) | 2012-10-23 | 2015-10-07 | F. Hoffmann-La Roche AG | Mglu2/3 antagonists for the treatment of autistic disorders |
CN107018661B (zh) * | 2014-08-01 | 2020-01-03 | 詹森药业有限公司 | 6,7-二氢吡唑并[1,5-a]吡嗪-4(5H)-酮化合物及其作为MGLUR2受体的负向别构调节剂的用途 |
-
2015
- 2015-07-27 JO JOP/2015/0178A patent/JO3601B1/ar active
- 2015-07-30 MX MX2017001453A patent/MX2017001453A/es active IP Right Grant
- 2015-07-30 KR KR1020177005638A patent/KR102531693B1/ko active IP Right Grant
- 2015-07-30 EP EP15742317.9A patent/EP3174880B1/en active Active
- 2015-07-30 US US15/500,553 patent/US10112949B2/en active Active
- 2015-07-30 BR BR112017001998A patent/BR112017001998A2/pt not_active Application Discontinuation
- 2015-07-30 TW TW104124697A patent/TWI696625B/zh not_active IP Right Cessation
- 2015-07-30 WO PCT/EP2015/067533 patent/WO2016016381A1/en active Application Filing
- 2015-07-30 EA EA201692496A patent/EA031038B1/ru not_active IP Right Cessation
- 2015-07-30 AU AU2015295299A patent/AU2015295299B2/en active Active
- 2015-07-30 CN CN201580041306.4A patent/CN106573935B/zh active Active
- 2015-07-30 JP JP2017505456A patent/JP6615864B2/ja active Active
- 2015-07-30 CA CA2954218A patent/CA2954218C/en active Active
- 2015-07-30 ES ES15742317T patent/ES2702192T3/es active Active
- 2015-07-31 AR ARP150102462A patent/AR101393A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP6615864B2 (ja) | 2019-12-04 |
TW201609742A (zh) | 2016-03-16 |
CA2954218C (en) | 2022-11-29 |
EP3174880B1 (en) | 2018-09-26 |
WO2016016381A1 (en) | 2016-02-04 |
BR112017001998A2 (pt) | 2017-12-12 |
EA031038B1 (ru) | 2018-11-30 |
JP2017523201A (ja) | 2017-08-17 |
EP3174880A1 (en) | 2017-06-07 |
ES2702192T3 (es) | 2019-02-27 |
EA201692496A1 (ru) | 2017-06-30 |
KR102531693B1 (ko) | 2023-05-10 |
US20180222908A1 (en) | 2018-08-09 |
AU2015295299A1 (en) | 2017-01-19 |
CN106573935A (zh) | 2017-04-19 |
CN106573935B (zh) | 2020-01-17 |
TWI696625B (zh) | 2020-06-21 |
US10112949B2 (en) | 2018-10-30 |
AU2015295299B2 (en) | 2019-05-02 |
AR101393A1 (es) | 2016-12-14 |
KR20170032464A (ko) | 2017-03-22 |
CA2954218A1 (en) | 2016-02-04 |
MX2017001453A (es) | 2017-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12017500161A1 (en) | 6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS | |
JO3368B1 (ar) | مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2 | |
PH12017500170A1 (en) | 6,7-dihydropyrazolo[1,5-a]pyrazin-4(5h)-one compounds and their use as negative allosteric modulators of mglur2 receptors | |
JO3601B1 (ar) | مركبات 6 ، 7 ثاني هيدرو بيرازولو [ 1، 5 الفا ] بيرازين – 4 (5 يد) – اون واستخدامها كمنظمات الوسترية سلبية لمستقبلات ملجور 2 | |
SG10201804868PA (en) | Compounds for the inhibition of indoleamine-2,3-dioxygenase | |
MX2018009257A (es) | Derivados de benzimidazol como moduladores de ror-gamma. | |
MX2016011632A (es) | Derivados de azaspiro como antagonistas de trpm8. | |
MY193728A (en) | Muscarinic receptor agonists | |
MX2019002180A (es) | Moduladores alostericos positivos del receptor m1 muscarinico. | |
NZ736055A (en) | Imidazopyrazines and pyrazolopyrimidines and their use as ampa receptor modulators | |
NZ740587A (en) | Fluoroindole derivatives as muscarinic m1 receptor positive allosteric modulators | |
MY192609A (en) | Substituted bicyclic heteroaryl compounds as rxr agonists | |
PH12016500312A1 (en) | 1,2,4-TRIAZOLO[4,3-a]PYRIDINE COMPOUNDS AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS | |
PH12016502480A1 (en) | Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases | |
IN2013MU03838A (ar) |